SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. Carey, M. Bruce, M. Horner, Y. Zen, L. D'Antiga, S. Bansal, D. Vergani, G. Mieli-Vergani, HBsAg plasma level kinetics: a new role for an old marker as a therapy response predictor in vertically infected children on combination therapy, Journal of Viral Hepatitis, 2015, 22, 4
  2. 2
    Margo J. H. van Campenhout, Harry L. A. Janssen, How to achieve immune control in chronic hepatitis B?, Hepatology International, 2015, 9, 1, 9

    CrossRef

  3. 3
    Yanwei Zhong, Shuangye Hu, Chen Xu, Yulai Zhao, Dongping Xu, Yanqing Zhao, Jingmin Zhao, Zhibin Li, Xiuchang Zhang, Hongfei Zhang, Jin Li, A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR, BMC Infectious Diseases, 2014, 14, 1, 608

    CrossRef

  4. 4
    Yujian Niu, Xinguo Chen, Lijuan Feng, Hong You, Xiuyun Ren, Haifeng Liu, Jingchen Zheng, Zhongyang Shen, Jidong Jia, Anti-HBc–positive/HBsAg-negative liver donors pose a higher risk of occult HBV infection but do not cause severe histological damage in liver grafts, Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 4, 475

    CrossRef

  5. 5
    Naoki Ogura, Koichi Watashi, Toru Noguchi, Takaji Wakita, Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line, Biochemical and Biophysical Research Communications, 2014, 452, 3, 315

    CrossRef

  6. 6
    Mahendran Chinnappan, Avishek Kumar Singh, Pavan Kumar Kakumani, Gautam Kumar, Sheetalnath Babasaheb Rooge, Anupama Kumari, Aditi Varshney, Archana Rastogi, Ashok Kumar Singh, Shiv Kumar Sarin, Pawan Malhotra, Sunil Kumar Mukherjee, Raj Kamal Bhatnagar, Key elements of the RNAi pathway are regulated by hepatitis B virus replication and HBx acts as a viral suppressor of RNA silencing, Biochemical Journal, 2014, 462, 2, 347

    CrossRef

  7. 7
    Bhupesh Singla, Anuradha Chakraborti, Bal Krishan Sharma, Shweta Kapil, Yogesh K. Chawla, Sunil K. Arora, Ashim Das, Radha K. Dhiman, Ajay Duseja, Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients, Molecular Biology Reports, 2014, 41, 7, 4689

    CrossRef

  8. 8
    Jaime Morales-Romero, Gustavo Vargas, Rebeca García-Román, Occult HBV Infection: A Faceless Enemy in Liver Cancer Development, Viruses, 2014, 6, 4, 1590

    CrossRef

  9. 9
    Hung-Chih Yang, Jia-Horng Kao, Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance, Emerging Microbes & Infections, 2014, 3, 9, e64

    CrossRef

  10. 10
    H.-M. V. Tang, W.-W. Gao, C.-P. Chan, Y. Cheng, V. Chaudhary, J.-J. Deng, K.-S. Yuen, C.-M. Wong, I. O.-L. Ng, K.-H. Kok, J. Zhou, D.-Y. Jin, Requirement of CRTC1 coactivator for hepatitis B virus transcription, Nucleic Acids Research, 2014, 42, 20, 12455

    CrossRef

  11. 11
    V. Loustaud-Ratti, A. Wagner, P. Carrier, V. Marczuk, I. Chemin, F. Lunel, I. Fouchard-Hubert, S. Si Ahmed, A. Abergel, A. Rousseau, A. Lefebvre, M. Debette-Gratien, F. Denis, S. Alain, Distribution of total DNA and cccDNA in serum and PBMCs may reflect the HBV immune status in HBsAg+ and HBsAg− patients coinfected or not with HIV or HCV, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 4, 373

    CrossRef

  12. 12
    Bo Young Min, Nam Young Kim, Eun Sun Jang, Cheol Min Shin, Sang Hyup Lee, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim, Ethanol potentiates hepatitis B virus replication through oxidative stress-dependent and -independent transcriptional activation, Biochemical and Biophysical Research Communications, 2013, 431, 1, 92

    CrossRef

  13. 13
    Turyadi, Meta Dewi Thedja, Susan Irawati Ie, Alida Roswita Harahap, Korri Elvanita El-Khobar, Martono Roni, David Handojo Muljono, HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients, Hepatology International, 2013, 7, 4, 969

    CrossRef

  14. 14
    Ambreen Ayub, Usman Ali Ashfaq, Asma Haque, HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level, BioMed Research International, 2013, 2013, 1

    CrossRef

  15. 15
    Satoru Hagiwara, Masatoshi Kudo, Yukio Osaki, Hiroo Matsuo, Tadashi Inuzuka, Akihiro Matsumoto, Eiji Tanaka, Toshiharu Sakurai, Kazuomi Ueshima, Tatsuo Inoue, Norihisa Yada, Naoshi Nishida, Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B, Journal of Medical Virology, 2013, 85, 6
  16. 16
    Kristie Bloom, Abdullah Ely, Claudio Mussolino, Toni Cathomen, Patrick Arbuthnot, Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases, Molecular Therapy, 2013, 21, 10, 1889

    CrossRef

  17. 17
    Claudia Cardoso, Ana L. Alves, Fátima Augusto, Ricardo Freire, Carlos Quintana, Matilde Gonçalves, Ana P. Oliveira, Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease, European Journal of Gastroenterology & Hepatology, 2013, 25, 2, 142

    CrossRef

  18. 18
    Fugui Bai, Yoshihiko Yano, Takumi Fukumoto, Atsushi Takebe, Motofumi Tanaka, Kaori Kuramitsu, Nungki Anggorowati, Hanggoro Tri Rinonce, Dewiyani Indah Widasari, Masaya Saito, Hirotaka Hirano, Takanobu Hayakumo, Yasushi Seo, Takeshi Azuma, Yonson Ku, Yoshitake Hayashi, Quantification of Pregenomic RNA and Covalently Closed Circular DNA in Hepatitis B Virus-Related Hepatocellular Carcinoma, International Journal of Hepatology, 2013, 2013, 1

    CrossRef

  19. 19
    Meirong Wang, Ning Qiu, Shichun Lu, Dianrong Xiu, Jianguo Yu, Xing tai Wang, Fengmin Lu, Tong Li, Xueen Liu, Hui Zhuang, Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma, Journal of Medical Virology, 2013, 85, 2
  20. 20
    Tassilo Volz, Lena Allweiss, Mounira Ben ḾBarek, Michael Warlich, Ansgar W. Lohse, Jörg M. Pollok, Alexander Alexandrov, Stephan Urban, Jörg Petersen, Marc Lütgehetmann, Maura Dandri, The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus, Journal of Hepatology, 2013, 58, 5, 861

    CrossRef

  21. 21
    Stephanos J. Hadziyannis, Vassilios Sevastianos, Irene Rapti, Dimitrios Vassilopoulos, Emilia Hadziyannis, Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir, Gastroenterology, 2012, 143, 3, 629

    CrossRef

  22. 22
    Rahmet Guner, Mustafa Karahocagil, Mehmet Buyukberber, Ozlem Kandemir, Onur Ural, Gaye Usluer, Dilara İnan, Iftihar Koksal, Nurcan Baykam, Kenan Hizel, Tansu Yamazhan, Saban Esen, Mehmet A. Tasyaran, Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection, European Journal of Gastroenterology & Hepatology, 2011, 23, 12, 1185

    CrossRef

  23. 23
    Emanuel K. Manesis, George V. Papatheodoridis, Dina G. Tiniakos, Emilia S. Hadziyannis, Olga P. Agelopoulou, Thalia Syminelaki, Christos Papaioannou, Theodoros Nastos, Peter Karayiannis, Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B, Journal of Hepatology, 2011, 55, 1, 61

    CrossRef

  24. 24
    Yang Ding, Li Ma, Xin-zhu Wang, Jian Zhang, Gui-zhen Zhao, Zhao-quan Wang, Xiao-guang Dou, In vitro Study on Hepatitis B Virus Infecting Human Choriocarcinoma JEG3 Cells and Its Mechanism, Intervirology, 2011, 54, 5, 276

    CrossRef

  25. 25
    Danny Ka Ho Wong, Fung Yu Huang, Ching Lung Lai, Ronnie Tung Ping Poon, Wai Kay Seto, James Fung, Ivan Fan Ngai Hung, Man Fung Yuen, Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma, Hepatology, 2011, 54, 3
  26. You have free access to this content26
    Rami Moucari, Patrick Marcellin, Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B, Liver International, 2011, 31,
  27. 27
    Yanwei Zhong, Jiaqi Han, Zhengsheng Zou, Shuhong Liu, Bo Tang, Xiaoqiang Ren, Xiaodong Li, Yulai Zhao, Yan Liu, Dongqing Zhou, Weijie Li, Jingmin Zhao, Dongping Xu, Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR, Clinica Chimica Acta, 2011, 412, 21-22, 1905

    CrossRef

  28. 28
    Jin-Wook Kim, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Replicative Activity of Hepatitis B Virus Is Negatively Associated with Methylation of Covalently Closed Circular DNA in Advanced Hepatitis B Virus Infection, Intervirology, 2011, 54, 6, 316

    CrossRef

  29. 29
    A. Gramenzi, E. Loggi, L. Micco, C. Cursaro, S. Fiorino, S. Galli, S. Gitto, C. Galli, G. Furlini, M. Bernardi, P. Andreone, Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients, Journal of Viral Hepatitis, 2011, 18, 10
  30. 30
    H. Lik-Yuen Chan, G. Lai-Hung Wong, C.-H. Tse, H.-Y. Chan, V. Wai-Sun Wong, Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients, Journal of Infectious Diseases, 2011, 204, 3, 408

    CrossRef

  31. 31
    Pisit Tangkijvanich, Piyawat Komolmit, Varocha Mahachai, Pattaratida Sa-nguanmoo, Apiradee Theamboonlers, Yong Poovorawan, Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B, Hepatology Research, 2010, 40, 3
  32. 32
    R. Bart Takkenberg, Hans L. Zaaijer, Sandra Menting, Christine J. Weegink, Valeska Terpstra, Marion Cornelissen, Marcel G.W. Dijkgraaf, Peter L.M. Jansen, Hendrik W. Reesink, Marcel G.H.M. Beld, Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients, European Journal of Gastroenterology & Hepatology, 2010, 22, 8, 952

    CrossRef

  33. 33
    Ying-Tang Gao, Tao Han, Ying Li, Bin Yang, Yi-Jun Wang, Feng-mei Wang, Xiang Jing, Zhi Du, Enhanced specificity of real-time PCR for measurement of hepatitis B virus cccDNA using restriction endonuclease and plasmid-safe ATP-dependent DNase and selective primers, Journal of Virological Methods, 2010, 169, 1, 181

    CrossRef

  34. 34
    Linda Wittkop, Alexandra Schwarz, Aurelia Cassany, Stefanie Grün-Bernhard, Mildred Delaleau, Birgit Rabe, Christian Cazenave, Wolfram Gerlich, Dieter Glebe, Michael Kann, Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation, Cellular Microbiology, 2010, 12, 7
  35. 35
    F. B. Hollinger, G. Sood, Occult hepatitis B virus infection: a covert operation, Journal of Viral Hepatitis, 2010, 17, 1
  36. 36
    Alexander J.V. Thompson, Tin Nguyen, David Iser, Anna Ayres, Kathy Jackson, Margaret Littlejohn, John Slavin, Scott Bowden, Edward J. Gane, William Abbott, George K.K. Lau, Sharon R. Lewin, Kumar Visvanathan, Paul V. Desmond, Stephen A. Locarnini, Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers, Hepatology, 2010, 51, 6
  37. 37
    Daniel Shouval, The search for a new endpoint for antiviral prophylaxis in hepatitis B virus transplanted patients, Digestive and Liver Disease, 2010, 42, 8, 537

    CrossRef

  38. 38
    Massimo Levrero, Teresa Pollicino, Jorg Petersen, Laura Belloni, Giovanni Raimondo, Maura Dandri, Control of cccDNA function in hepatitis B virus infection, Journal of Hepatology, 2009, 51, 3, 581

    CrossRef

  39. 39
    Yanhai Guo, Yongnian Li, Shijie Mu, Ju Zhang, Zhen Yan, Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication, Journal of Medical Virology, 2009, 81, 7
  40. 40
    L. Lu, H.-Y. Zhang, Y.-H. Yueng, K.-F. Cheung, J. M. Luk, F.-S. Wang, G. K. K. Lau, Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients, Journal of Viral Hepatitis, 2009, 16, 2
  41. 41
    Arema A. Pereira, Ira M. Jacobson, Modern diagnosis of HBV infection, Current Hepatitis Reports, 2009, 8, 1, 18

    CrossRef

  42. 42
    Maura Dandri, Jörg Petersen, John M. Murray, Reply:, Hepatology, 2009, 49, 5
  43. 43
    Tin Nguyen, Paul Desmond, Stephen Locarnini, The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B, Hepatology International, 2009, 3, S1, 5

    CrossRef

  44. 44
    R.B. Takkenberg, H.L. Zaaijer, R. Molenkamp, S. Menting, V. Terpstra, C.J. Weegink, M.G.W. Dijkgraaf, P.L.M. Jansen, H.W. Reesink, M.G.H.M. Beld, Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients, Journal of Medical Virology, 2009, 81, 6
  45. 45
    F. Blaine Hollinger, Hepatitis B virus infection and transfusion medicine: science and the occult, Transfusion, 2008, 48, 5
  46. 46
    J.-M. Pawlotsky, Les techniques virologiques de diagnostic et de suivi de l’hépatite B, Gastroentérologie Clinique et Biologique, 2008, 32, 1, S56

    CrossRef

  47. 47
    D. Scott Bowden, Alex J. Thompson, New developments in HBV molecular diagnostics and quantitative serology, Hepatology International, 2008, 2, S1, 3

    CrossRef

  48. 48
    Jean–Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, Daryl Lau, George Lau, T. Jake Liang, Stephen Locarnini, Paul Martin, Douglas D. Richman, Fabien Zoulim, Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach, Gastroenterology, 2008, 134, 2, 405

    CrossRef

  49. 49
    Tassilo Volz, Marc Lutgehetmann, Paul Wachtler, Anna Jacob, Alexander Quaas, John M. Murray, Maura Dandri, Joerg Petersen, Impaired Intrahepatic Hepatitis B Virus Productivity Contributes to Low Viremia in Most HBeAg-Negative Patients, Gastroenterology, 2007, 133, 3, 843

    CrossRef

  50. 50
    Fuat H Saner, Ali Canbay, Guido Gerken, Christoph E Broelsch, Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome, Expert Review of Gastroenterology & Hepatology, 2007, 1, 2, 207

    CrossRef

  51. 51
    Munira Hussain, Consuelo Soldevila-Pico, Sukru Emre, Velimir Luketic, Anna S.F. Lok, Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation, Liver Transplantation, 2007, 13, 8
  52. 52
    Alex Thompson, Stephen Locarnini, Kumar Visvanathan, The Natural History and the Staging of Chronic Hepatitis B: Time for Reevaluation of the Virus–Host Relationship Based on Molecular Virology and Immunopathogenesis Considerations?, Gastroenterology, 2007, 133, 3, 1031

    CrossRef